Short Interest in PharmaCielo Ltd. (OTCMKTS:PCLOF) Decreases By 39.2%

PharmaCielo Ltd. (OTCMKTS:PCLOF) was the recipient of a large drop in short interest in April. As of April 30th, there was short interest totaling 52,246 shares, a drop of 39.2% from the April 15th total of 85,990 shares. Based on an average daily trading volume, of 215,929 shares, the days-to-cover ratio is presently 0.2 days.

PharmaCielo Trading Down 9.0%

PharmaCielo stock traded down $0.01 during midday trading on Friday, reaching $0.06. The company had a trading volume of 64,186 shares, compared to its average volume of 71,111. PharmaCielo has a 12-month low of $0.00 and a 12-month high of $0.12. The firm’s fifty day simple moving average is $0.04 and its 200-day simple moving average is $0.04.

About PharmaCielo

PharmaCielo (OTCMKTS:PCLOF) is a Colombia-based, vertically integrated cannabinoid extraction and manufacturing company that develops pharmaceutical-grade active ingredients for the global medical cannabis market. The company specializes in the cultivation, extraction, purification and isolation of cannabinoids, producing a range of high-purity oils, distillates and isolates that serve as the active pharmaceutical ingredients (APIs) in end-use formulations. PharmaCielo’s product portfolio is designed to meet Good Manufacturing Practices (GMP) standards, enabling partnerships with pharmaceutical firms and wellness brands seeking compliant, consistently standardized cannabinoid inputs.

Since commencing operations, PharmaCielo has established a state-of-the-art extraction facility in Colombia, leveraging the country’s favorable agronomic conditions and regulatory framework for medicinal cannabis cultivation.